共 50 条
- [6] Differing Efficacy of Dapagliflozin Versus Empagliflozin on the Risk of Incident Atrial Fibrillation in Patients With Type 2 Diabetes: A Real-World Observation Using a Nationwide, Population-Based Cohort [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (03):
- [7] Cardiovascular Outcomes With Empagliflozin and Dapagliflozin in Patients Without Diabetes [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2024, 218 : 24 - 31
- [9] Comparative cardiovascular and hypoglycaemic safety of glimepiride in type 2 diabetes: A population-based cohort study [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (02): : 254 - 262